| 1 |
Onyameh EK, Ofori E, Bricker BA, Gonela UM, Eyunni SVK, Kang HJ, Voshavar C, Ablordeppey SY. Design and discovery of a high affinity, selective and β-arrestin biased 5-HT7 receptor agonist. Med Chem Res 2022;31:274-83. [DOI: 10.1007/s00044-021-02797-4] [Reference Citation Analysis]
|
| 2 |
Kułaga D, Drabczyk AK, Satała G, Latacz G, Rózga K, Plażuk D, Jaśkowska J. Design and synthesis of new potent 5-HT7 receptor ligands as a candidate for the treatment of central nervous system diseases. Eur J Med Chem 2022;227:113931. [PMID: 34710746 DOI: 10.1016/j.ejmech.2021.113931] [Reference Citation Analysis]
|
| 3 |
Adamo D, Calabria E, Coppola N, Pecoraro G, Mignogna MD. Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update. Ther Adv Psychopharmacol 2021;11:20451253211034320. [PMID: 34497709 DOI: 10.1177/20451253211034320] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Loebel A, Koblan KS, Tsai J, Deng L, Fava M, Kent J, Hopkins SC. A Randomized, Double-blind, Placebo-controlled Proof-of-Concept Trial to Evaluate the Efficacy and Safety of Non-racemic Amisulpride (SEP-4199) for the Treatment of Bipolar I Depression. J Affect Disord 2022;296:549-58. [PMID: 34614447 DOI: 10.1016/j.jad.2021.09.109] [Reference Citation Analysis]
|
| 5 |
Fukuyama K, Okada M. Effects of an Atypical Antipsychotic, Zotepine, on Astroglial L-Glutamate Release through Hemichannels: Exploring the Mechanism of Mood-Stabilising Antipsychotic Actions and Antipsychotic-Induced Convulsion. Pharmaceuticals (Basel) 2021;14:1116. [PMID: 34832898 DOI: 10.3390/ph14111116] [Reference Citation Analysis]
|
| 6 |
Fukuyama K, Nakano T, Shiroyama T, Okada M. Chronic Administrations of Guanfacine on Mesocortical Catecholaminergic and Thalamocortical Glutamatergic Transmissions. Int J Mol Sci 2021;22:4122. [PMID: 33923533 DOI: 10.3390/ijms22084122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Shiroyama T, Fukuyama K, Okada M. Distinct Effects of Escitalopram and Vortioxetine on Astroglial L-Glutamate Release Associated with Connexin43. Int J Mol Sci 2021;22:10013. [PMID: 34576176 DOI: 10.3390/ijms221810013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Fukuyama K, Okada M. Effects of Atypical Antipsychotics, Clozapine, Quetiapine and Brexpiprazole on Astroglial Transmission Associated with Connexin43. Int J Mol Sci 2021;22:5623. [PMID: 34070699 DOI: 10.3390/ijms22115623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Ślifirski G, Król M, Turło J. 5-HT Receptors and the Development of New Antidepressants. Int J Mol Sci 2021;22:9015. [PMID: 34445721 DOI: 10.3390/ijms22169015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Asada R, Ogushi Y, Hori H, Kawasaki H. Successful treatment for major depressive disorder with psychotic features with addition of asenapine on escitalopram. Psychogeriatrics 2022. [PMID: 35141987 DOI: 10.1111/psyg.12812] [Reference Citation Analysis]
|
